DexCom
DXCM
#846
Rank
NZ$47.55 B
Marketcap
NZ$121.28
Share price
-1.30%
Change (1 day)
-22.21%
Change (1 year)

Earnings for DexCom (DXCM)

Earnings in 2025 (TTM): NZ$1.68 Billion

According to DexCom's latest financial reports the company's current earnings are NZ$4.51 Billion. In 2024 the company made an earning of NZ$1.20 Billion a decrease over its 2023 earnings that were of NZ$1.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for DexCom from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$1.68 B39.24%
2024 NZ$1.20 B-0.37%
2023 NZ$1.21 B78.13%
2022 NZ$0.68 B47.34%
2021 NZ$0.46 B-10.11%
2020 NZ$0.51 B88.27%
2019 NZ$0.27 B-258.48%
2018 -NZ$0.18 Billion189.94%
2017 -NZ$59.45 Million-44.24%
2016 -NZ$0.11 Billion12.43%
2015 -NZ$94.81 Million165.58%
2014 -NZ$35.7 Million-25.61%
2013 -NZ$47.99 Million-48.11%
2012 -NZ$92.48 Million24.5%
2011 -NZ$74.28 Million
2008 -NZ$87.72 Million13.18%
2007 -NZ$77.51 Million-5.36%
2006 -NZ$81.9 Million52.08%
2005 -NZ$53.85 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$53.79 B 3,212.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$13.51 B 732.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$10.64 B 555.42%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Becton Dickinson
BDX
NZ$3.12 B 92.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Edwards Lifesciences
EW
NZ$2.83 B 74.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-NZ$0.35 Billion-120.95%๐Ÿ‡บ๐Ÿ‡ธ USA
QuidelOrtho
QDEL
-NZ$1.89 Billion-216.18%๐Ÿ‡บ๐Ÿ‡ธ USA
West Pharmaceutical Services
WST
NZ$1.00 B-38.21%๐Ÿ‡บ๐Ÿ‡ธ USA